Representatives of the Permanent Mission of Turkmenistan to the United Nations Office in Geneva met with officials from the Swiss pharmaceutical company La Roche to discuss ongoing joint projects. The talks focused on providing medical support to children suffering from rare diseases, including hemophilia and spinal muscular atrophy (SMA).
As reported by the UN Permanent Mission in Geneva on Tuesday, under the current initiatives, patients are receiving essential medications that significantly improve their quality of life and reduce the risk of disability.
The two sides also discussed long-term access to therapy, training of medical professionals, and the transfer of diagnostic materials.
Representatives of the Swiss company confirmed their interest in sustainable and long-term cooperation with the Turkmen side.
La Roche was founded in 1896 and became one of the first companies to produce industrial pharmaceutical products in Switzerland, Germany, and Italy.
30635-495x4352.jpg)
30457-495x4352.jpg)
30635-90x604.jpg)
30625-90x604.jpeg)
_(1)30624-90x604.jpg)
